Norges Bank
IMMU

Norges Bank’s Immunomedics Inc IMMU Stock Holding History

Norges Bank’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,316,348
Closed -$197M – 2208
2020
Q3 		$197M Buy
2,316,348
+172,912
+8% +$8.74M 0.05% 325
2020
Q2 		$76M Buy
2,143,436
+430,566
+25% +$12.6M 0.02% 616
2020
Q1 		$23.1M Sell
1,712,870
-65,490
-4% -$1.1M 0.01% 1154
2019
Q4 		$37.6M Buy
1,778,360
+100,000
+6% +$1.76M 0.01% 1098
2019
Q3 		$22.3M Buy
1,678,360
+237,856
+17% +$3.5M 0.01% 1415
2019
Q2 		$20M Buy
1,440,504
+92,479
+7% +$1.39M 0.01% 1502
2019
Q1 		$25.9M Buy
1,348,025
+216,918
+19% +$3.5M 0.01% 1322
2018
Q4 		$16.1M Buy
1,131,107
+159,391
+16% +$3.16M 0.01% 1529
2018
Q3 		$20.2M Buy
971,716
+92,081
+10% +$2.18M 0.01% 1519
2018
Q2 		$20.8M Buy
879,635
+5,436
+0.6% +$109K 0.01% 1496
2018
Q1 		$12.8M Buy
+874,199
New +$14.3M ﹤0.01% 1659
2016
Q4 		– Sell
-400,000
Closed -$1.24M – 2179
2016
Q3 		$1.24M Hold
400,000
– – ﹤0.01% 2021
2016
Q2 		$928K Buy
+400,000
New +$1.34M ﹤0.01% 2074

Norges Bank's IMMU Position: Q4 2020 in Review

Norges Bank sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,316,348 shares — an estimated $197M sold.

Norges Bank first reported a position in IMMU in Q2 2016 and held it in 13 quarters. The position peaked at $197M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Norges Bank reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Norges Bank sold 2,316,348 Immunomedics Inc shares in Q4 2020, an estimated $197M.
  • Norges Bank first reported a position in Immunomedics Inc in Q2 2016 and held it in 13 quarters.
  • Norges Bank's Immunomedics Inc position peaked at $197M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.